Cholestyramine Powder, For Suspension
Product Images NDC 24658-266

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cholestyramine (NDC 24658-266). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Puracap Laboratories Llc Dba Blu Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Regular-carton-right.jpg (Carton Right)

Regular-carton-right.jpg (Carton Right)
The text partially shows the title of a document related to the preparation of Cholestyramine for oral suspension in the USP. However, without the complete context and content, it is not possible to provide a more detailed description.*
FDA Label Image

Regular-can.jpg (Regular Can)

FDA Label Image

Regular-carton-left.jpg (Regular Left)

FDA Label Image

Structure-formula.jpg (Structure Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.